AVISE Lupus


The Advanced Lupus Test

Powered by CB-CAPs Technology





AVISE® Lupus is a 10-marker diagnostic test containing Cell-Bound Complement Activation Products (CB-CAPs) and SLE associated markers designed to aid healthcare providers in a timely differential diagnosis of SLE.

What is included in AVISE Lupus?

Biomarkers AVISE Lupus AVISE CTD
10-marker Lupus diagnostic test containing Cell-Bound Complement Activation Products (CB-CAPs)
X
X
AVISE Index Calculation Value
X
X
Extractable Nuclear Antigen (ENA) Panel  
X
Rheumatoid Arthritis Panel  
X
Antiphospholipid Syndrome – APS panel  
X
Thyroid panel  
X

AVISE Lupus contains the following biomarkers:

AVISE® Lupus contains patented Lupus (SLE) biomarkers, CB-CAPs, which help to offer a 22% greater sensitivity than C3/C4, and 48% greater sensitivity than anti-dsDNA.





Clinical Utility:

The AVISE Lupus test is an ideal test for ANA positive patients with a clinical suspicion of lupus.

Testing method:

The AVISE Lupus test is composed of a two-tier testing method:


Image

AVISE Lupus Test Report:

References:

  1. Cell-bound complement activation products in SLE. Ramsey-Goldman R, et al. Lupus Science and Medicine. 2017.
  2. Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements. Putterman C. et al. Lupus Science and Medicine. 2014.
  3. Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products. Wallace D. et al. Lupus Science & Medicine. 2016.
  4. The AVISE Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus. Mossell J. et al. The Open Rheumatology Journal. 2016.

View Complete References

To learn more about AVISE testing please click the link below.


Learn More